The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Exercise Capacity in De-Novo Heart Transplant Recipients: Results of the SCHEDULE Trial After 36 Months

被引：0
|
作者：
Arora, S. [1 ]
Gude, E. [1 ]
Karason, K. [2 ]
Andersson, B. [2 ]
Bartfay, S. [2 ]
Solbu, D. [3 ]
Dellgren, G. [2 ]
Andreassen, A. [1 ]
Gullestad, L. [1 ]
机构：
[1] Natl Hosp Norway, Oslo Univ Hosp, Cardiol, Oslo, Norway
[2] Sahlgrens Univ Hosp, Cardiol, Gothenburg, Sweden
[3] Novartis Norge, Oslo, Norway
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2017年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
925
引用
收藏
页码：S299 / S299
页数：1
相关论文
共 50 条
  • [41] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 3 Year Data of the APOLLO Trial
    Rath, T.
    Budde, K.
    Sommerer, C.
    Haller, H.
    Suwelack, B.
    May, C.
    Paulus, E. -M
    Witzke, O.
    Reinke, P.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 994 - 994
  • [42] TWO YEAR DATA OF THE APOLLO TRIAL: RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS
    Reinke, P.
    Haller, H.
    Rath, T.
    Arns, W.
    Paulus, E. -M.
    Scheidl, S.
    Witzke, O.
    Sommerer, C.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 50
  • [43] RENAL FUNCTION IN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM TREATED DE NOVO LIVING RENAL TRANSPLANT RECIPIENTS AFTER CALCINEURIN INHIBITOR WITHDRAWAL: SUBGROUP ANALYSIS OF THE ZEUS STUDY
    Lehner, F.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Paulus, E. -M.
    Scheidl, S.
    Witzke, O.
    Budde, K.
    Sommerer, C.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 51
  • [44] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 24 MONTHS
    Duvoux, C.
    Saliba, F.
    Durand, F.
    Neau-Cransac, N.
    Hardwigsen, J.
    Pageaux, G.
    Boleslawski, E.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 2
  • [45] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 12 MONTHS
    Saliba, Faouzi
    Duvoux, Christophe
    Durand, Francois
    Neau-Cransac, Martine
    Hardwigsen, Jean
    Pageaux, Georges
    Boleslawski, Emmanuel
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 : 39 - 39
  • [46] EFFECT OF EARLY CONVERSION TO EVEROLIMUS ON CARDIOVASCULAR PARAMETERS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: RESULTS FROM THE ELEVATE STUDY
    Holdaas, Hallvard
    Van Der Giet, Markus
    De Fijter, Johan W.
    Speziale, Antonio
    Escrig, Cesar
    Junge, Guido
    Wang, Zailong
    Cruzado, Josep M.
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 209 - 210
  • [47] ELEVATE: an innovative study design to assess the efficacy, safety, and evolution of cardiovascular parameters in de novo kidney transplant recipients after early conversion from a calcineurin inhibitor to everolimus
    van der Giet, Markus
    Cruzado, Josep M.
    de Fijter, Johan W.
    Holdaas, Hallvard
    Wang, Zailong
    Speziale, Antonio
    Junge, Guido
    [J]. OPEN ACCESS JOURNAL OF CLINICAL TRIALS, 2014, 6 : 17 - 27
  • [48] OUTCOME ON RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS: 5 YEAR DATA OF THE APOLLO TRIAL
    Rath, T.
    Sommerer, C.
    Suwelack, B.
    Arns, W.
    Haller, H.
    Reinke, P.
    Budde, K.
    Baeumer, D.
    Porstner, M.
    Witzke, O.
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 50 - 50
  • [49] Outcome on Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 4 Year Data of the APOLLO Trial
    Budde, K.
    Sommerer, C.
    Reinke, P.
    Haller, H.
    Arns, W.
    Witzke, O.
    Suwelack, B.
    May, C.
    Baeumer, D.
    Paulus, E.
    Rath, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 311 - 312
  • [50] DE NOVO DONOR-SPECIFIC ANTIBODY FORMATION AFTER CONVERSION FROM CALCINEURIN INHIBITOR TO EVEROLIMUS VS. SIROLIMUS IN RENAL TRANSPLANT RECIPIENTS
    Bertram, S.
    Seidel, M.
    Waldecker, C. B.
    Rohn, B.
    Bauer, F.
    Viebahn, R.
    Westhoff, T. H.
    Babel, N.
    Seibert, F. S.
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 45 - 45
12345